PharmFormulator is a source-linked research platform with over 1,200 U.S. ophthalmic drug-product records, including ...

WeGuide Pty Ltd will receive A$1.9 million to build a world first platform in developing commercial multi-modal biomarkers.

Kyverna Therapeutics' miv-cel showed improved mobility and a favorable safety profile at one year in patients with stiff ...

Beijing, China, September 24, 2026 — Pulmongene Ltd. (“Pulmongene” or “the Company”), a clinical-stage biotechnology company ...

While Acadia Pharmaceuticals’ candidate has missed the main goal of a Phase 2 trial, the company is still moving forward with the anti-psychosis candidate in Alzheimer’s disease as well as Lewy body ...

ARCT-810 generally safe and well tolerated, demonstrating encouraging activity across key urea cycle biomarkers in ongoing ...

ERZOFRI® is a LAI with the highest available initiation dose of paliperidone palmitate to simplify treatment initiation for ...

While artificial intelligence can help biotech and pharma companies more quickly vet job applicants, it can also turn off the ...

Tech darling Enveda has raised a total of $845 million in the past six years. The latest funding round is intended to pave ...

The weekly insulin Onswik will now be available to U.S. patients after initial approvals in Europe, Mexico and Japan.

NAPLES, Fla.-- (BUSINESS WIRE)--Catalyst OrthoScience, Inc. ("Catalyst"), a private medical technology company elevating ...

After imeroprubart failed to demonstrate sufficient efficacy in lupus during a Phase 2b trial, Immunovant is moving on from ...